Michael E Kasper, MD

Zdenka Ena Segota, M.D., is a board-certified hematologist oncologist with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. Her clinical interests include breast cancer and hematologic malignancies such as lymphoma and myeloma. Dr. Segota has extensive research experience, putting her at the forefront of innovations in cancer care. During her career, she has served as principal investigator or sub-investigator on numerous clinical trials that have resulted in the development of many new oncology medications. These studies aim to improve patients’ pre-surgical and post-surgical outcomes as well as metastatic cancer survival rates. Dr. Segota earned her medical degree at the University of Zagreb, School of Medicine in Croatia. She completed an internal medicine internship and residency at Cleveland Clinic Health System, Huron Hospital. Her extensive training also includes a hematology and medical oncology fellowship and experimental therapeutics research fellowship at Cleveland Clinic Cancer Center, Taussig Cancer Institute. Dr. Segota enjoys connecting and interacting with her patients and believes that every person deserves to receive an individual approach to cancer care. She offers patients precision medicine through genomic testing. This type of testing identifies disease-associated variants to help match patients to more personalized therapies or assess a patient’s disease risk and help target more effective therapies. Dr. Segota speaks English and Croatian. In her free time, she enjoys traveling, gardening, renovating houses and spending time with her family.

Matthen Mathew, M.D., is a board-certified medical oncologist at the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital, with expertise in lung cancer, head and neck cancer, and benign hematology. Before joining Baptist Health, Dr. Mathew was an assistant professor of medicine in the Division of Hematology-Oncology, Vagelos College of Physicians and Surgeons at Columbia University. Dr. Mathew earned his medical degree at University of Florida College of Medicine. He completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, where he was selected to be chief resident. He then completed fellowship training in hematology and medical oncology at New York Presbyterian Hospital/ColumbiaUniversity Medical Center, where he was appointed chief fellow. In addition to his clinical expertise, Dr. Mathew has extensive experience in clinical trials research and immuno-oncology. He has been the site principal investigator for large, national cooperative group studies and has also designed and implemented trials focused on advancing new and more effective treatments for patients. He is a member of the American Society of Clinical Oncology and the American Board of Internal Medicine. Dr. Mathew believes a multidisciplinary approach to treatment is crucial for cancer care. His approach to patient care involves working together with the rest of the cancer care team — from surgeons to social workers — to ensure that patients have a strong support network during treatment. In his free time, Dr. Mathew enjoys spending time with his wife and three sons. His favorite activities include going to the beach, playing tennis and golfing.

Stephen Grabelsky, M.D., is a hematologist and medical oncologist at the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. Dr. Grabelsky has a special interest in treating gastrointestinal and gynecologic cancer. Prior to joining Lynn Cancer Institute in 1996, Dr. Grabelsky was on staff at the JFK Medical Center Comprehensive Cancer Institute. He’s currently a clinical affiliate associate professor at Florida Atlantic University. Dr. Grabelsky was inspired to become a physician after his mother was diagnosed with breast cancer while he was in high school. Hisapproach to patient care is to look at the situation from the perspective of his patient and their family, not only as a purveyor of medical information. When appropriate, Dr. Grabelsky encourages his patients to participate in clinical trials, which offer the latest treatment approaches. He serves as a principal investigator and sub-investigator on several clinical trials. When he is not treating patients, Dr. Grabelsky enjoys spending time with his family and traveling.